Physician profile
Jacob Goldstein
NPI 1003896374
$2,741.48
in general payments reported to CMS, 2019-2025
11 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $387 · 2021: $348 · 2022: $321 · 2024: $106 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $754 · Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $754.22 |
| Food and Beverage | $409.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $854.22 | 2025 | Motoband |
| Depuy Synthes Sales INC. | $557.59 | 2022-2025 | Tfn-Advance, Motoband, N/A |
| Trilliant Surgical LLC. | $388.42 | 2019 | |
| Abiomed | $281.92 | 2020-2021 | |
| Treace Medical Concepts, INC. | $266.11 | 2020 | |
| Orthofix Medical, INC. | $133.70 | 2019 | |
| In2bones USA, LLC | $89.70 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $66.56 | 2021 | |
| Nevro Corp. | $56.00 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $30.60 | 2021 | |
| Linvatec Corporation | $16.66 | 2025 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.